NSE: COFORGE | BSE: 532541

Mid-range Performer

Download real time

1852.80 1.80 (0.10%)

55.17% Gain from 52W Low

154.1K NSE+BSE Volume

NSE 15 Dec, 2025 10:41 AM (IST)

62,049.6

Market Cap

High in industry

Beta 1Year

Very High Volatility

Coforge Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COFORGE, BSE:532541 Coforge Ltd.

Search Inside the pdf :

Coforge Ltd.

09 Dec 2025

1852.80

0.10%

Company Update:Coforge

Buy: Coforge Ltd.

Target

Axis Direct

We recommend a BUY on the stock and value the company at 38x multiple to its FY27E earnings to arrive at a TP of Rs 2,300/share, implying an upside of 18% from the CMP.

Coforge Ltd. is trading above all available SMAs

Coforge Ltd.

09 Dec 2025

1852.80

0.10%

Strong execution focus and proactive deal shaping drive strong growth despite weak demand

Hold: Coforge Ltd.

Target

ICICI Securities Limited

We attended Coforge’s analyst meet, wherein management reiterated its strategy of proactive large deal win focus; strong execution focus, with rewards for top sales leaders; specialised expertise in select industry segments of BFS, Insurance, travel and efforts to scale up healthcare and UK public sector.

Coforge Ltd. has an average target of 2256.67 from 8 brokers.

Coforge Ltd.

09 Dec 2025

1852.80

0.10%

Investor Day 2025: On strong footing

Buy: Coforge Ltd.

Target

Motilal Oswal

We attended Coforge’s Investor Day 2025 wherein the management discussions were largely centered on strategic objectives, growth vectors and execution intensity.

Number of FII/FPI investors decreased from 659 to 622 in Sep 2025 qtr

Coforge Ltd.

09 Dec 2025

1852.80

0.10%

Coforge Ltd.

Buy: Coforge Ltd.

Target

ICICI Direct

Hyper-specialisation + Large-deal engine driving growth: We attended Coforge's Investor Day 2025, wherein the management highlighted Coforge's proactive, non-RFP (request for proposal) large-deal strategy and deep domain specialisation across BFS, Insurance, Travel and Healthcare which position it for sustained industry-leading growth into FY28E. Coforge closed 6 large deals in H1FY25 and is targeting 20 by year-end, with cloud and AI embedded in two-thirds of wins. Travel is set for a deep acceleration in the next 12 months, while...

Number of FII/FPI investors decreased from 659 to 622 in Sep 2025 qtr

Coforge Ltd.

27 Oct 2025

1852.80

0.10%

Result Update:Coforge

Buy: Coforge Ltd.

Target

Axis Direct

Given the company's strong growth potential, backed by robust deal wins and superior execution capabilities, we maintain our BUY rating on the stock.

Number of FII/FPI investors decreased from 659 to 622 in Sep 2025 qtr

Coforge Ltd.

27 Oct 2025

1852.80

0.10%

Consistent execution on all fronts

Hold: Coforge Ltd.

ICICI Securities Limited

Coforge reported strong revenue growth of 5.9% QoQ CC, led by ramp-up of Sabre mega deal and BFS deal conversions (five large deals signed in Q1FY26). Operating margin was robust with 251bps QoQ expansion on lower SG&A and employee costs.

Motilal Oswal increased Buy price target of Coforge Ltd. to 3000.0 on 09 Dec, 2025.

Coforge Ltd.

27 Oct 2025

1852.80

0.10%

Coforge Ltd.

Buy: Coforge Ltd.

ICICI Direct

Coforge Ltd (Coforge) is a digital services and solutions provider that leverages its domain experience across sectors such as Banking & Financial Services, Insurance, Government, Travel, Transport and Hospitality....

Motilal Oswal increased Buy price target of Coforge Ltd. to 3000.0 on 09 Dec, 2025.

Coforge Ltd.

27 Oct 2025

1852.80

0.10%

Coforge (COFORGE): Q2FY26 Result Review

Buy: Coforge Ltd.

Target

IDBI Capital

Coforge reported a strong Q2FY26 with consolidated revenue of INR 3,855 crore (USD 462mn), growing 8.1%/26.7% QoQ/YoY in INR terms, driven by robust growth in Travel (+6.4%), Healthcare, Retail & Hi-Tech (+5.9%), Insurance (+1.8%), and BFSI (+4%) sectors. EBIT margin expanded 251bps QoQ to 14%, supported by lower ESOP costs and operating leverage, despite higher hedge losses. PAT margin improved to 9.4%. Order intake reached USD 514mn with five large deals, lifting the executable order book to USD 1.63bn, up 26.7% YoY. Employee strength increased to ~35K with a low attrition rate of 11.4% and...